Metabolic-Immune Reprogramming via CuZnS@BSA Nanoregulators to Overcome Resistance in Triple-Negative Breast Cancer.

Theranostics · 2026 · PMC13440635 · PMID 42559282

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The results were striking: whereas both monotherapies had some anti-metastatic activity, the combination exerted highly significant metastasis suppression (Figure 8 B), confirmed by H&E staining which showed the fewest pulmonary metastatic nodules (Figure 8 C) and a 50% reduction in lung weight compared to PBS controls.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.